CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents

CYP2C19 loss-of-function (LOF) alleles adversely affect clinical outcome of clopidogrel therapy. Recent introduction of a newer-generation drug-eluting stent (DES) has significantly reduced the occurrence of stent thrombosis. The aim of this study was to evaluate the impact of CYP2C19 LOF alleles on...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ik Jun, Koh, Yoon-Seok, Park, Mahn-Won, Her, Sung Ho, Choi, Yun-Seok, Park, Chul-Soo, Park, Hun-Jun, Kim, Pum-Joon, Chung, Wook-Sung, Kim, Ho-Sook, Shin, Jae-Gook, Seung, Ki-Bae, Chang, Kiyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937952/
https://www.ncbi.nlm.nih.gov/pubmed/27368038
http://dx.doi.org/10.1097/MD.0000000000004049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937952/
https://www.ncbi.nlm.nih.gov/pubmed/27368038
http://dx.doi.org/10.1097/MD.0000000000004049

Ejemplares similares